Glenview Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
21,317
+746
| +4% | +$51.5K | 0.03% | 238 |
|
|
2025
Q1 | $1.43M | Buy |
20,571
+5
| +0% | +$347 | 0.03% | 234 |
|
|
2024
Q4 | $1.77M | Buy |
20,566
+7,369
| +56% | +$634K | 0.03% | 216 |
|
|
2024
Q3 | $1.57M | Buy |
13,197
+3,790
| +40% | +$451K | 0.03% | 230 |
|
|
2024
Q2 | $1.34M | Buy |
9,407
+129
| +1% | +$18.4K | 0.03% | 233 |
|
|
2024
Q1 | $1.19M | Buy |
9,278
+2,216
| +31% | +$285K | 0.03% | 242 |
|
|
2023
Q4 | $731K | Buy |
7,062
+714
| +11% | +$73.9K | 0.02% | 285 |
|
|
2023
Q3 | $577K | Buy |
6,348
+182
| +3% | +$16.6K | 0.02% | 295 |
|
|
2023
Q2 | $499K | Buy |
6,166
+348
| +6% | +$28.2K | 0.01% | 320 |
|
|
2023
Q1 | $463K | Buy |
5,818
+1,300
| +29% | +$103K | 0.01% | 327 |
|
|
2022
Q4 | $306K | Hold |
4,518
| – | – | 0.01% | 365 |
|
|
2022
Q3 | $225K | Hold |
4,518
| – | – | 0.01% | 384 |
|
|
2022
Q2 | $252K | Buy |
4,518
+128
| +3% | +$7.14K | 0.01% | 369 |
|
|
2022
Q1 | $244K | Hold |
4,390
| – | – | 0.01% | 388 |
|
|
2021
Q4 | $246K | Hold |
4,390
| – | – | 0.01% | 382 |
|
|
2021
Q3 | $211K | Buy |
+4,390
| New | +$211K | 0.01% | 389 |
|
|
2018
Q1 | – | Sell |
-14,626
| Closed | -$392K | – | 334 |
|
|
2017
Q4 | $392K | Hold |
14,626
| – | – | 0.03% | 260 |
|
|
2017
Q3 | $352K | Hold |
14,626
| – | – | 0.03% | 258 |
|
|
2017
Q2 | $314K | Hold |
14,626
| – | – | 0.02% | 265 |
|
|
2017
Q1 | $250K | Buy |
14,626
+1,100
| +8% | +$18.8K | 0.02% | 288 |
|
|
2016
Q4 | $243K | Buy |
+13,526
| New | +$243K | 0.02% | 280 |
|